Greenway, F.; Loveridge, B.; Grimes, R.M.; Tucker, T.R.; Alexander, M.; Hepford, S.A.; Fontenot, J.; Nobles-James, C.; Wilson, C.; Starr, A.M.;
et al. Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology. Int. J. Mol. Sci. 2022, 23, 1884.
https://doi.org/10.3390/ijms23031884
AMA Style
Greenway F, Loveridge B, Grimes RM, Tucker TR, Alexander M, Hepford SA, Fontenot J, Nobles-James C, Wilson C, Starr AM,
et al. Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology. International Journal of Molecular Sciences. 2022; 23(3):1884.
https://doi.org/10.3390/ijms23031884
Chicago/Turabian Style
Greenway, Frank, Brian Loveridge, Richard M. Grimes, Tori R. Tucker, Michael Alexander, Scott A. Hepford, Justin Fontenot, Candi Nobles-James, Carol Wilson, Adam M. Starr,
and et al. 2022. "Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology" International Journal of Molecular Sciences 23, no. 3: 1884.
https://doi.org/10.3390/ijms23031884
APA Style
Greenway, F., Loveridge, B., Grimes, R. M., Tucker, T. R., Alexander, M., Hepford, S. A., Fontenot, J., Nobles-James, C., Wilson, C., Starr, A. M., Abdelsaid, M., Lewis, S. T., & Lakey, J. R. T.
(2022). Physiologic Insulin Resensitization as a Treatment Modality for Insulin Resistance Pathophysiology. International Journal of Molecular Sciences, 23(3), 1884.
https://doi.org/10.3390/ijms23031884